TRANSEPI Trademark

Trademark Overview

On Thursday, June 20, 2013, a trademark application was filed for TRANSEPI with the United States Patent and Trademark Office. The USPTO has given the TRANSEPI trademark a serial number of 85965343. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Sunday, August 15, 2021. This trademark is owned by Avidas Pharmaceuticals LLC. The TRANSEPI trademark is filed in the Pharmaceutical Products category with the following description:

A proprietary dermatological delivery system, namely, drug delivery formulations sold as an integral ingredient of pharmaceutical preparations for the topical and transdermal delivery of a wide range of cosmetic ingredients, namely, micronutrients, antioxidants and sun-protecting ingredients
transepi

General Information

Serial Number85965343
Word MarkTRANSEPI
Filing DateThursday, June 20, 2013
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateSunday, August 15, 2021
Registration Number4625776
Registration DateTuesday, October 21, 2014
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 24, 2013

Trademark Statements

Goods and ServicesA proprietary dermatological delivery system, namely, drug delivery formulations sold as an integral ingredient of pharmaceutical preparations for the topical and transdermal delivery of a wide range of cosmetic ingredients, namely, micronutrients, antioxidants and sun-protecting ingredients
Pseudo MarkTRANSDERMAL EPI

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 2, 2013
Primary Code005
First Use Anywhere DateFriday, July 11, 2014
First Use In Commerce DateFriday, July 11, 2014

Trademark Owner History

Party NameAvidas Pharmaceuticals LLC
Party Type30 - Original Registrant
Legal Entity Type16 - Limited Liability Company
AddressDoylestown, PA 18901
Party NameAvidas Pharmaceuticals LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressDoylestown, PA 18901
Party NameAvidas Pharmaceuticals LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressDoylestown, PA 18901

Trademark Events

Event DateEvent Description
Tuesday, October 29, 2013EXAMINERS AMENDMENT -WRITTEN
Monday, June 24, 2013NEW APPLICATION ENTERED
Tuesday, July 2, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, July 3, 2013NOTICE OF PSEUDO MARK E-MAILED
Saturday, September 28, 2013ASSIGNED TO EXAMINER
Saturday, September 28, 2013NON-FINAL ACTION WRITTEN
Saturday, September 28, 2013NON-FINAL ACTION E-MAILED
Saturday, September 28, 2013NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, October 29, 2013EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2013NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, October 29, 2013EXAMINER'S AMENDMENT ENTERED
Tuesday, February 18, 2014NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, October 29, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, November 18, 2013ASSIGNED TO LIE
Monday, November 18, 2013LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, December 4, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 24, 2013PUBLISHED FOR OPPOSITION
Tuesday, December 24, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 16, 2014ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, August 15, 2014TEAS STATEMENT OF USE RECEIVED
Friday, August 15, 2014USE AMENDMENT FILED
Monday, September 8, 2014STATEMENT OF USE PROCESSING COMPLETE
Friday, September 5, 2014CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, September 9, 2014ASSIGNED TO EXAMINER
Tuesday, September 16, 2014SU-EXAMINER'S AMENDMENT WRITTEN
Tuesday, September 16, 2014EXAMINERS AMENDMENT E-MAILED
Tuesday, September 16, 2014NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 16, 2014EXAMINER'S AMENDMENT ENTERED
Wednesday, September 17, 2014NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Monday, October 21, 2019COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, October 21, 2014REGISTERED-PRINCIPAL REGISTER
Tuesday, April 20, 2021TEAS SECTION 8 & 15 RECEIVED
Sunday, August 15, 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Sunday, August 15, 2021REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Sunday, October 20, 2024TEAS SECTION 8 & 9 RECEIVED
Saturday, October 21, 2023COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sunday, August 15, 2021NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

transepi delivery ingredients namely range wide transdermal cosmetic micronutrients protecting antioxidants